Issue 17, 1991

An effective chelating agent for labelling of monoclonal antibody with 212Bi for α-particle mediated radioimmunotherapy

Abstract

The ligand N-[2-amino-3-(p-isothiocyanatophenyl)propyl]-(±)-trans-1,2-diaminocyclohexane-N,N′,N″-pentaacetic acid has been synthesized and linked to IgG and to monoclonal antibody B72.3, and labelled with 206Bi and 212Bi to demonstrate the in vivo stability of the label and its utility for 212Bi-radioimmunotherapy.

Article information

Article type
Paper

J. Chem. Soc., Chem. Commun., 1991, 1169-1170

An effective chelating agent for labelling of monoclonal antibody with 212Bi for α-particle mediated radioimmunotherapy

M. W. Brechbiel, C. G. Pippin, T. J. McMurry, D. Milenic, M. Roselli, D. Colcher and O. A. Gansow, J. Chem. Soc., Chem. Commun., 1991, 1169 DOI: 10.1039/C39910001169

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements